NovAccess Global Inc. (OTCMKTS:XSNX – Get Free Report) was the target of a significant decrease in short interest in July. As of July 15th, there was short interest totalling 2,700 shares, a decrease of 25.0% from the June 30th total of 3,600 shares. Based on an average daily trading volume, of 53,500 shares, the days-to-cover ratio is presently 0.1 days.
NovAccess Global Price Performance
Shares of OTCMKTS:XSNX opened at $0.01 on Monday. The business’s 50 day simple moving average is $0.01 and its 200 day simple moving average is $0.01. The company has a market capitalization of $401,400.00, a P/E ratio of -0.07 and a beta of 1.85. NovAccess Global has a 1 year low of $0.00 and a 1 year high of $0.12.
NovAccess Global (OTCMKTS:XSNX – Get Free Report) last issued its earnings results on Wednesday, May 15th. The company reported ($0.02) earnings per share for the quarter.
NovAccess Global Company Profile
NovAccess Global Inc, a biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States. It specializes in cutting-edge research related to utilizing a patient's immune system to attack the cancer. The company was incorporated in 1997 and is headquartered in Chagrin Falls, Ohio.
Featured Articles
- Five stocks we like better than NovAccess Global
- Top Stocks Investing in 5G Technology
- Is Crypto Cool Again? What Stocks You Should Be Watching
- Investing in Commodities: What Are They? How to Invest in Them
- Why Call Options Volume for These 2 Stocks Spiked Together
- What Are Dividend Achievers? An Introduction
- MarketBeat Week in Review – 7/22 – 7/26
Receive News & Ratings for NovAccess Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NovAccess Global and related companies with MarketBeat.com's FREE daily email newsletter.
